NEWS

consequences of hospital-acquired infections

The consequences of hospital-acquired infections

What are the consequences of hospital-acquired infections? Health consequences of hospital-acquired infections In France, hospital-acquired infections are responsible for 9,000 deaths per year, of which 4,200 involve patients whose prognosis was not vital in the short term when they entered … Read More

Featured Post
hospital-acquired infections

What causes hospital-acquired infections?

 Previous article: How to fight against nosocomial diseases? What causes hospital-acquired infections? The development of a nosocomial infection, also known as a healthcare-associated infection, is possible when three elements are present: a subject (the elderly, for example, have a higher … Read More

Featured Post
Risk of infection in the hospital environment

How to fight against nosocomial infections?

According to the WHO, a nosocomial infection – or hospital-acquired infection – can be defined as an infection acquired in hospital by a patient admitted for an other reason than the infection itself.  How are infections acquired?  Bacterial infections can … Read More

Featured Post

Research Scientist member arrival

New Research Scientist at SPARTHA Medical Developping of innovative coatings with biopolymers In order to pursue research projects related to our innovation, we announce the arrival of a new Research Scientist in the team. Our mission is to develop the … Read More

Featured Post
Antibiotic resistance

Antibiotic-resistant superbugs are officially one of the leading causes of death in the world. 

Antibiotic-resistant superbugs are officially one of the leading causes of death in the world. Antibiotics are drugs used to treat and prevent bacterial infections. Antibiotic resistance occurs with repeated administration of antibiotics. Consequently, as antibiotics target their cellular machinery, bacteria … Read More

Featured Post

Impact of cell culture environments on the performance of biosensors

Publication from PANBioRA project: the impact of cell culture environments on the performance of various electrochemical biosensors The Wiley Analytical Science published an article entitled « Characterization of the Impact of Classical Cell-culture Media on the Response of Electrochemical Sensors » thanks … Read More

Featured Post

Laureate of the EIC Accelerator

The EIC Accelerator is the European Innovation Council’s (EIC) programme for SMEs. Launched by the European Commission in September 2019 in its pilot phase ahead of Horizon Europe. The EIC aims to stimulate Europe’s economic growth by enabling visionary and … Read More

Featured Post

SPARTHA Medical raised €1.4M

SPARTHA MEDICAL COMPLETES ITS FIRST ROUND OF FUNDING TO DEVELOP ITS CUSTOMISED COATINGS OFFER (€1.4M) Strasbourg, FRANCE, 8 Decembre 2021. SPARTHA Medical, a French MedTech company specialising in the development of multifunctional antimicrobial, antiviral and anti-inflammatory coatings, is pleased to … Read More

Featured Post

Senet ‘s first conceptual proposal workshop

In the framework of the Sino European Health Networking Hub (SENET), discover the first conceptual proposal workshop on the theme of advanced therapies, which will take place on 19 October. Dr. Nihal Engin Vrana will be speaking on the topic … Read More

Featured Post

Newcomers in the team

Newcomers in the team SPARTHA Medical The #TeamSpartha is growing! In order to pursue SPARTHA Medical’s vision to grow and be a key player in the healthcare industry, we are pleased to announce the arrival of new employees who proudly … Read More

Featured Post

Research and development approval (CIR)

SPARTHA Medical has been granted for CIR accreditation SPARTHA Medical is pleased to announce the company has been granted for CIR accreditation for research and development (R&D) after scientific and technical expertise. • What does it mean ? The Research Tax Credit … Read More

Featured Post

Development of coatings using artificial intelligence: a world premiere.

Development of coatings using artificial intelligence: a world premiere. A collaboration between SPARTHA Medical, Preste and INSERM has resulted in publication of a pioneering paper in their areas of expertise in the journal Scientific Reports. Data from the scientific literature … Read More

Featured Post

US patent publication

Strasbourg, 10 June 2021. SPARTHA Medical, French MedTech company specializing in the development of multifonctional antimicrobial, antiviral and anti-inflammatory coatings, is pleased to announce the registration of its patent in the formulation of polymer-based coatings in the United States (US10864296B2). … Read More

Featured Post

Interview Business Inside | Forbes France

Issues and innovations around antibacterial coatings. SPARTHA Medical co-founders, Nihal Engin Vrana (Chief Executive Officer) and Philippe Lavalle (Chief Scientific Officer) have been interviewed by Jean Marc Sylvestre for the business TV show ”Business Inside”, in partnership with Forbes France. … Read More

Featured Post

43 TOP scoring 2020 InvestHorizon Accelerator companies

InvestHorizon is a programme financed by the European Commission, in association with Eureka, to facilitate series A funding for selected deep tech companies boosting their investment readiness and investor relations. The programme is run by a consortium coordinated by Tech … Read More

Featured Post

Selected among the 100 startups to invest in by Challenges

‘100 startups to invest in’ selection Released each year by the magazine Challenges, the 2021 edition of the ‘100 startups to invest in’ selection has included SPARTHA Medical. The top 100 SPARTHA’s presentation ”Our selection in this ranking marks a … Read More

Featured Post

SPARTHA Medical in the french news – March & April 2020

APRIL 2021 SPARTHA Medical presented its development and innovation objectives in this interview, published in the national news website actu.fr. SPARTHA Medical was featured in the local magazine Or Norme for the creation of a regional start-up incubation network called … Read More

Featured Post

The first organ-on-chip network in France

SPARTHA MEDICAL IS PART OF THE FIRST ORGAN-ON-CHIP INDUSTRY IN FRANCE. Structured by the BioValley France network in order to support and accelerate the emergence of innovative technologies, the network brings together major pharmaceutical and dermo-cosmetic industrial groups as well as research … Read More

Featured Post

SPARTHA Medical finished Innouvo Program

We are very pleased to have participated in this partnership adventure between the cities of Strasbourg and Boston, which will enable us to develop our activities for the American market. This program is in addition to the two other programs … Read More

Featured Post

SPARTHA Medical FUNDRAISING

Spartha Medical launched a Fundraising Campain in October 2020 … Read More

Featured Post